Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/24/24
End: 03/27/26
Due: 03/27/27
Phase: N/A
Priority: Normal
Start: 04/18/25
End: 07/25/25
Due: 07/25/26
Phase: N/A
Priority: Normal
Start: 12/27/23
End: 08/01/24
Due: 08/01/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Research Study of VCT220 in Adult Chinese Participants With Obesity | NCT06939296 | Vincentage Pharma Co., Ltd | user2@example.com | None | 2024-12-24 | 2026-03-27 | 2027-03-27 | - | - | 2025-07-14 |
| A Pharmacokinetic Study of VCT220 in Particicants With Hepatic Injury and Normal Hepatic Function | NCT06938529 | Vincentage Pharma Co., Ltd | user2@example.com | None | 2025-04-18 | 2025-07-25 | 2026-07-25 | - | - | 2025-07-14 |
| A Study to Evaluate the Efficacy and Safety of VCT220 in Obesity Chinese Population | NCT06569355 | Vincentage Pharma Co., Ltd | user2@example.com | None | 2023-12-27 | 2024-08-01 | 2025-08-01 | - | - | 2025-07-14 |